The whole world of commodities in one App!

Watch Management & Expert Interviews, Site-Visit-Videos, News Shows and receive top and up to date Mining Information on your mobile device worldwide!

Download our unique App for free!
Commodity-TV Play Store
Commodity-TV App Store

Social Media

Population services

The world population is growing and hunger is spreading. There's still a lot to do.

Receive up-to-date information about the company directly via push notification

According to the United Nations, the number of starving people has been rising again since the middle of the decade. About 820 million people are starving. A frightening number. Africa is particularly affected. Weak economic development, floods, droughts and conflicts have a causal effect. About two billion people are malnourished. The goal of the United Nations to eradicate world hunger by 2030 seems utopian.

The world population will grow from 7.7 billion people today to an estimated 9.7 billion by 2050. One company that deals with food and pharmaceutical products is EnWav - The company can dehydrate and preserve food and pharmaceutical products with the help of fast, cost-effective drying. EnWave recently signed a licence agreement with Kameya Foods. Wasabi, vegetables and seafood are dried.

EnWave's innovation has also found its way into the booming cannabis industry. For example, Glasshouse Botanics will use EnWave's technology for high-quality medical cannabis.

With the current interest in cannabis companies one cannot get past RavenQuest BioMed - The company is active in several areas: the cultivation of cannabis of the highest quality, research and development and an innovative orbital garden 2.0 technology. These are rotating gardens that offer the plants the best conditions fully automatically - and give the company a technical advantage over the competition. For 2020, RavenQuest BioMed anticipates a turnover of 90 million CanDollar, with an upward trend.

Current company information and press releases from EnWave ( and RavenQuest BioMed (

In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the German version of these messages applies.

Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: 

Always up to date with the newsletter from SRC

Swiss Resource Capital AG will use the information you provide in this form to keep in touch with you and to provide you with updates and marketing information. To receive our news, you still have to give us permission to send you E-Mails below.

You can change your mind at any time by clicking on the Unsubscribe link, which you can find in the footer of every email you receive from us, or by contacting us at [email protected] We will treat your information with care and respect. For more information about our privacy practices, visit our website. By clicking below, you agree that we may process your information in accordance with these Terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

* indicates required
SRC Mining & Special Situations ZertifikatSRC Mining & Special Situations Zertifikat